Drug discovery

It gives me great pleasure in writing a testimonial about our company's experience of Neovirtech. During the COVID Pandemic, a time of extraordinary upheaval globally, we engaged the contract research services of Neovirtech, following recommendation, to specifically examine a number of our platform recombinant products against SARS-CoV-2 and a number of the more recently described variants in their state of the art Biosafety Level 3 Laboratory. From the design, implementation, troubleshooting, quality assurance, speed of deliverables and standard of work, we have been utterly impressed by every aspect of their professionalism and communication during at least 12 months of continuous work on several of our projects. The entire team is to be commended, with particular mention of their CEO Franck Gallardo, who is outstanding. I have worked with many in the scientific field of academia and drug discovery from Imperial College, Harvard and Tufts Universities, as well as countless CROs spanning over twenty years, and as such, I can say without reservation that Neovirtech are one of the best. It is no surprise that they are regularly nominated and win innovation awards on a national stage.

We are developing inhibitors of intracellular trafficking pathways that block virus entry into cells. NeoVirTech’s technology allows for precise ranking of sets of analogues according to their antiviral potencies and selectivity indexes. Working with NeoVirTech was a great experience. Preparatory discussions were rich and efficient, adaptation of protocols to our needs was very successful, antiviral screening of our molecules was done rapidly, and activity reports were clear and informative. The team was always available to answer our questions. We warmly recommend NeoVirTech for the screening and potency assessment of antiviral molecules on designated viruses.

Neovirtech have carried out several anti-viral studies for MicroA, on a range of targets. Both before and after the studies, we were impressed with their quick responses to our queries, very thorough technical approach and their support in data interpretation. Many thanks to the Neovirtech team for their hard work!